Hospital Universitario Del Vinalopo
- Address
- lock Available on a paid plan
Diagnostic Imaging and Breast Cancer Research
At Hospital Universitario Del Vinalopo, the Radiology department is actively involved in studies that connect advanced imaging with cancer care, especially in breast cancer. This work focuses on improving diagnosis and helping doctors better understand how imaging findings relate to surgical and pathology results.
- Breast cancer imaging and surgical correlation
- Multiparametric MRI and diagnostic value assessment
- Support for more accurate cancer detection and treatment planning
These trials aim to strengthen diagnostic techniques and refine how imaging can guide care for patients with early and advanced breast cancer.
Cardiovascular and Thromboembolic Studies
The site is also contributing to research in cardiovascular diseases, with a strong focus on acute pulmonary embolism and venous thromboembolism. These studies are designed to evaluate treatment effectiveness and improve outcomes for patients at risk of serious clot-related complications.
- Acute pulmonary embolism management
- Venous thromboembolism in patients with cancer
- Assessment of therapies aimed at reducing recurrence and improving recovery
Research in this area helps clarify which approaches may offer better protection and safer care for patients with complex clotting disorders.
Oncology Trials Across Multiple Cancer Types
A major part of the clinical research portfolio at Hospital Universitario Del Vinalopo centers on neoplasms, including breast cancer, head and neck squamous cell carcinoma, and ROS1-positive non-small cell lung cancer. These studies explore new treatment strategies and test whether combining therapies can improve survival and disease control.
- Early-stage and metastatic breast cancer
- Head and neck squamous cell carcinoma
- Non-small cell lung cancer with brain metastasis
The overall goal is to evaluate more effective cancer treatments while also tracking how tumors respond over time.
Hematology and Blood Disorder Research
The hematology portfolio includes studies in polycythemia vera and chronic myeloid leukemia, reflecting the site’s interest in diseases of the blood and bone marrow. These trials are centered on testing new therapies and understanding how they may help control disease activity and reduce treatment burden.
- Polycythemia vera symptom and disease control
- Chronic phase chronic myeloid leukemia treatment response
- Evaluation of targeted approaches for blood-related cancers
This research supports the search for more precise and better-tolerated options in hemic and lymphatic diseases.
Immune and Kidney Disease Investigations
Clinical trials at the site also extend into immune system diseases and kidney disorders, including primary membranous nephropathy. These studies are intended to assess whether emerging treatments can improve disease control and help protect kidney function.
- Primary membranous nephropathy
- Immune-related disease management
- Testing new therapies for better clinical response
This work broadens the research profile beyond cancer and imaging, showing a wider interest in complex chronic diseases.
Musculoskeletal and Pain Management Research
The site is involved in studies on musculoskeletal diseases, particularly chronic non-specific low back pain. These trials focus on understanding how to improve pain relief when standard non-opioid approaches have not provided enough benefit or are not suitable.
- Chronic non-specific low back pain
- Evaluation of pain reduction strategies
- Support for patients with limited response to prior treatment
The aim is to identify better options for managing persistent pain and improving daily function.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 40 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital Universitario Del Vinalopo
lock Showing 1 of 16 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b/3 Adaptive, Randomized, Active controlled Study Evaluating the Efficacy, Safety, and Tolerability of Povetacicept Versus Calcineurin Inhibitor in the Treatment of Primary Membranous Nephropathy | Vertex Pharmaceuticals Inc. | Phase IV | Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 40 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abelacimab | 2 | Unknown | 2022-08-10 | 2022-09-13 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.